Showing results (1051-1060 of 1,490) with videos related to

Sort By:
Pageof 149
Chemotherapy|June 10, 2024
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center ExperienceEdy Ippolito, Francesco Pantano, Sonia Silipigni, et al.
Journal of Biomaterials Science. Polymer Edition|March 22, 2018
Preparation of gelatin nanoparticles by two step desolvation method for application in photodynamic therapyJanicy Arantes Carvalho, Alexandro Silva Abreu, Vitória Tonini Porto Ferreira, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 1, 2016
Patient experience assessment in pediatric hospitals in ArgentinaNora Dackiewicz, Susana Rodriguez, Vilma Irazola, et al.
Tumori|September 21, 2016
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and consValentina Sini, Alessandra Cassano, Domenico Corsi, et al.
Expert Opinion on Biological Therapy|August 25, 2020
Denosumab for cancer-related bone lossEmanuela Dell'Aquila, Grazia Armento, Michele Iuliani, et al.
Frontiers in Oncology|June 5, 2012
Deregulation of ion channel and transporter encoding genes in pediatric gliomasMarika Masselli, Pasquale Laise, Giulia Tonini, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcomeC C Raggi, M Maggi, D Renzi, et al.
Oncology Reports|April 6, 2006
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumoursDaniele Santini, Bruno Vincenzi, Rosemary A Hannon, et al.
Critical Reviews in Oncology/Hematology|August 5, 2019
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trialsDaniele Santini, Antonio Galvano, Francesco Pantano, et al.
Plos One|October 3, 2012
In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomasGiuseppe Perrone, Laura Maria Gaeta, Mariagiovanna Zagami, et al.
Pageof 149